Biofil Chemicals EBITDA vs. Current Valuation

BIOFILCHEM   59.20  0.19  0.32%   
Based on Biofil Chemicals' profitability indicators, Biofil Chemicals Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Biofil Chemicals' ability to earn profits and add value for shareholders.
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
13 M
Current Value
12.9 M
Quarterly Volatility
7.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
For Biofil Chemicals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biofil Chemicals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biofil Chemicals Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biofil Chemicals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biofil Chemicals Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Biofil Chemicals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofil Chemicals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofil Chemicals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biofil Chemicals Pha Current Valuation vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biofil Chemicals's current stock value. Our valuation model uses many indicators to compare Biofil Chemicals value to that of its competitors to determine the firm's financial worth.
Biofil Chemicals Pharmaceuticals is number one stock in ebitda category among its peers. It also is the top company in current valuation category among its peers reporting about  73.24  of Current Valuation per EBITDA. At present, Biofil Chemicals' EBITDA is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Biofil Chemicals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biofil Chemicals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Biofil Current Valuation vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Biofil Chemicals

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
13 M
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Biofil Chemicals

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
951.8 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Biofil Current Valuation vs Competition

Biofil Chemicals Pharmaceuticals is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 379.83 Billion. Biofil Chemicals adds roughly 951.8 Million in current valuation claiming only tiny portion of equities under Health Care industry.

Biofil Chemicals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biofil Chemicals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biofil Chemicals will eventually generate negative long term returns. The profitability progress is the general direction of Biofil Chemicals' change in net profit over the period of time. It can combine multiple indicators of Biofil Chemicals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income320.3 M258.5 M
Operating Income20.7 M21.7 M
Income Before Tax8.7 M8.6 M
Total Other Income Expense Net-12 M-11.4 M
Net Income7.1 M9.3 M
Income Tax Expense1.6 M1.9 M
Net Income From Continuing Ops7.1 M9.1 M
Net Income Applicable To Common Shares6.4 M9.2 M
Net Interest Income-415 K-435.8 K
Interest Income488.8 K290.8 K
Change To Netincome584.2 K898.9 K

Biofil Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biofil Chemicals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biofil Chemicals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biofil Chemicals' important profitability drivers and their relationship over time.

Use Biofil Chemicals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofil Chemicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will appreciate offsetting losses from the drop in the long position's value.

Biofil Chemicals Pair Trading

Biofil Chemicals Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to Biofil Chemicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biofil Chemicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biofil Chemicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biofil Chemicals Pharmaceuticals to buy it.
The correlation of Biofil Chemicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biofil Chemicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biofil Chemicals Pha moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biofil Chemicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biofil Chemicals position

In addition to having Biofil Chemicals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Basic Utilities Thematic Idea Now

Basic Utilities
Basic Utilities Theme
Companies involved in production and distribution of electric, gas, water, and other energy utilities. The Basic Utilities theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Basic Utilities Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Biofil Stock

To fully project Biofil Chemicals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biofil Chemicals Pha at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biofil Chemicals' income statement, its balance sheet, and the statement of cash flows.
Potential Biofil Chemicals investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biofil Chemicals investors may work on each financial statement separately, they are all related. The changes in Biofil Chemicals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biofil Chemicals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.